A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor | Synapse
March 26, 2020Open Access
A positron emission tomography imaging study to confirm target engagement in the lungs of patients with idiopathic pulmonary fibrosis following a single dose of a novel inhaled αvβ6 integrin inhibitor
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.
Resumen
clinicaltrials.gov: NCT03069989; date of registration: 3 March 2017.